Swiss venture capital market continues upward trend

26 January 2023 12:54

Zurich CCGreater Zurich

Lucerne/Rotkreuz/Zurich - The Swiss venture capital market has recorded a record high once more for 2022. This is the result of the latest Swiss Venture Capital Report. ICT and cleantech startups attracted the most capital. More than half of all investments went to the canton of Zurich, followed by the canton of Vaud in second place.

The Swiss venture capital market has proven to be untouched by the adversities of the general economic situation for the year 2022. The total volume of investments in technology-based startups amounted to almost 4 billion Swiss francs. This corresponds to a plus of 29.7 percent versus the prior year. The invested venture capital (VC) has almost doubled since 2020 and more than quadrupled since 2017.

These are the results from the most recent Swiss Venture Capital Report. It is published by the online news portal and SECA, an investor association based in Zug, in collaboration with the platform.

The three largest funding rounds were concluded by Climeworks from Zurich with 600 million, SonarSource from Geneva with 394.6 million, and Wefox, again from Zurich, with 392 million Swiss francs. The total number of financing rounds increased by 7.9 percent in 2022 year on year.

The foreword to the report states that this continued upswing proves that this is not a bubble but is healthy growth, adding that it is “not surprising” that the number of Swiss VC fund projects is also steadily increasing. At the end of 2022, there were 55 VC funds in the fundraising phase.

An above-average increase in investments was recorded by ICT and fintech startups. They accounted for more than 2 billion Swiss francs, thus making up over half of the total sum for 2022. Cleantech stands out as well with 826.9 million Swiss francs, which is four times as much as 2021.

Together, Zurich-based startups drew in more than 50 percent of all Swiss investments. As before, the canton of Vaud is in second place, with 66.8 percent of all of its investments in the medtech sector. There was also clear growth in Geneva and Zug. Basel-City felt the decline in the biotech sector, where invested venture capital fell by 60.2 percent. In contrast, St.Gallen’s venture capital more than doubled versus 2021 and is now over the 100 million mark for the first time, at 122.8 million Swiss francs. mm

Swiss Pavilion Digital

Previous newsletters